JPWO2018163176A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018163176A5
JPWO2018163176A5 JP2019549378A JP2019549378A JPWO2018163176A5 JP WO2018163176 A5 JPWO2018163176 A5 JP WO2018163176A5 JP 2019549378 A JP2019549378 A JP 2019549378A JP 2019549378 A JP2019549378 A JP 2019549378A JP WO2018163176 A5 JPWO2018163176 A5 JP WO2018163176A5
Authority
JP
Japan
Prior art keywords
oil
formulation
polyoxyethylene
esters
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549378A
Other languages
English (en)
Japanese (ja)
Other versions
JP7250689B2 (ja
JP2020514342A (ja
JP2020514342A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2018/050265 external-priority patent/WO2018163176A1/en
Publication of JP2020514342A publication Critical patent/JP2020514342A/ja
Publication of JPWO2018163176A5 publication Critical patent/JPWO2018163176A5/ja
Publication of JP2020514342A5 publication Critical patent/JP2020514342A5/ja
Application granted granted Critical
Publication of JP7250689B2 publication Critical patent/JP7250689B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549378A 2017-03-07 2018-03-07 活性化合物のための局所送達系 Active JP7250689B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762467863P 2017-03-07 2017-03-07
US62/467,863 2017-03-07
PCT/IL2018/050265 WO2018163176A1 (en) 2017-03-07 2018-03-07 Topical delivery systems for active compounds

Publications (4)

Publication Number Publication Date
JP2020514342A JP2020514342A (ja) 2020-05-21
JPWO2018163176A5 true JPWO2018163176A5 (https=) 2022-12-27
JP2020514342A5 JP2020514342A5 (https=) 2022-12-27
JP7250689B2 JP7250689B2 (ja) 2023-04-03

Family

ID=61692208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549378A Active JP7250689B2 (ja) 2017-03-07 2018-03-07 活性化合物のための局所送達系

Country Status (8)

Country Link
US (2) US20210137829A1 (https=)
EP (1) EP3592336A1 (https=)
JP (1) JP7250689B2 (https=)
CN (1) CN110545796A (https=)
AU (1) AU2018231842B2 (https=)
CA (1) CA3055159A1 (https=)
IL (1) IL268773B2 (https=)
WO (1) WO2018163176A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3076555B1 (fr) * 2018-01-11 2020-01-24 Jafer Enterprises R&D Sl Materiau polymerique solide impregne d'une substance organique volatile et d'un ester particulier et ses utilisations
WO2020123306A1 (en) 2018-12-14 2020-06-18 Mary Kay Inc. Cosmetic compositions
EP3986383A4 (en) * 2019-06-20 2023-07-19 Lyotropic Delivery Systems Ltd. POLYMERIC FLEXIBLE FILMS INCLUDING NANODOMAINS AND/OR A BIOACTIVE AGENT AND METHODS FOR PRODUCING THEM
CN114401770A (zh) * 2019-09-29 2022-04-26 莱雅公司 用于护理角蛋白材料的化妆品组合物
CN110960682B (zh) * 2019-12-13 2020-12-25 厦门大学 一种pH调控凝胶高压后融化态时长增强药物负载的方法
US20230113554A1 (en) * 2019-12-16 2023-04-13 Ao Technology Ag Non-stick antibiotic gels
CN111632191B (zh) * 2020-05-11 2021-12-17 西安理工大学 一种释药磷酸钙基骨水泥的制备方法
US12109290B2 (en) 2020-12-29 2024-10-08 Kao Usa Inc. Hair shine compositions
EP4112043A1 (en) * 2021-06-30 2023-01-04 GSK Consumer Healthcare SARL Nano-complex composition comprising diclofenac
CN113786382B (zh) * 2021-11-04 2024-05-28 浙江得恩德制药股份有限公司 一种盐酸特比萘芬凝胶及制备方法
EP4342450A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic topical diclofenac formulations
EP4342449A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic single phase gel compositions for topical delivery of diclofenac
WO2025062440A1 (en) * 2023-09-20 2025-03-27 Pulse Pharmaceuticals Pvt. Ltd Topical nano-dispersion compositions and their preparation thereof
US20250099369A1 (en) * 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs
WO2025153330A1 (en) * 2024-01-15 2025-07-24 JeNaCell GmbH Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose
WO2025193822A1 (en) * 2024-03-13 2025-09-18 Menning Mark Michael Aqueous compositions of poorly water-soluble compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660554B1 (fr) * 1990-04-05 1992-07-03 Oreal Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spherouides hydrates d'une substance lipidique hydrophile.
JPH06509099A (ja) 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
AU2953497A (en) 1996-05-13 1997-12-05 Novartis Consumer Health S.A. Topical composition
US7182950B2 (en) 2002-06-12 2007-02-27 Nutralease Ltd. Nano-sized self-assembled liquid dilutable vehicles
EP1598060A1 (en) 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
CN101360481A (zh) 2005-11-22 2009-02-04 雀巢技术公司 水包油乳液及其用于功能性输送的用途
EP1963270B1 (en) 2005-12-09 2009-08-05 Cerecon AG Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
WO2008058366A1 (en) 2006-09-28 2008-05-22 Université de Montréal Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
GB0704846D0 (en) 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
CA2697458C (en) 2007-06-08 2016-02-09 Troikaa Pharmaceuticals Ltd. Non-aqueous topical solution of diclofenac and process for preparing the same
EP2055298A1 (en) 2007-10-30 2009-05-06 Novartis AG Topical composition
US20100099766A1 (en) 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
SG10201401297QA (en) * 2009-04-08 2014-08-28 Cadila Healthcare Ltd Stable pharmaceutical compositions of diclofenac
CN102151268B (zh) * 2011-03-28 2012-10-17 王义明 一种治疗阿尔茨海默症的复方制剂及其制备方法
CN104428003B (zh) 2012-07-12 2020-03-10 辉凌公司 双氯芬酸制剂
CN103655459A (zh) * 2013-12-19 2014-03-26 中国药科大学 一种多功能微乳凝胶制剂及其制备工艺
CA2959601A1 (en) * 2014-09-10 2016-03-17 Novartis Ag Topical diclofenac sodium compositions
CN113788831B (zh) * 2021-10-15 2023-01-17 常州大学 二氢吲嗪并吡咯酮衍生物及类似物及其合成方法

Similar Documents

Publication Publication Date Title
JPWO2018163176A5 (https=)
AU2014359195B2 (en) Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
LU101384B1 (en) Encapsulated Cannabinoid Formulations For Transdermal Delivery
Esposito et al. Nanomedicines to treat skin pathologies with natural molecules
US10716781B2 (en) Topical retinoid compositions
CN1150889C (zh) 水飞蓟素的口服微乳剂组合物
EP2616053B1 (en) Pharmaceutical compositions of curcumin
RU2013147429A (ru) Композиция, содержащая липидные наночастицы и кортикостероид или производное витамина d
RU2011148140A (ru) Самомикроэмульгирующаяся оральная фармацевтическая композиция, содержащая гидрофильное лекарственное средство, и способ ее приготовления
US8992994B2 (en) Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
JP2009533341A5 (https=)
KR20150014522A (ko) 레티노이드 함유 마이크로캡슐, 이의 제조 방법 및 이를 함유하는 약학 조성물
JP6276433B2 (ja) マイクロエマルション前濃縮物及びマイクロエマルション、並びにその調製工程
KR20120026050A (ko) 디클로페낙의 안정한 약학적 조성물
EP1970048A1 (en) Polyaphron topical composition with vitamin D
CN103110578A (zh) 一种灯盏花素磷脂复合物自微乳组合物及其制备方法
CN1286529C (zh) 具有皮肤靶向性的药物组合物及其制备方法和用途
IL298032A (en) Compositions for delivery of bioactive agents into hair follicles
JP2015131790A5 (https=)
RU2019129711A (ru) Системы доставки для местного нанесения для активных веществ
US9789123B2 (en) Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
EP4534072A1 (en) Non-aqueous pharmaceutical gel formulation containing dissolved adapalene
CN103655217B (zh) 一种原花青素微乳眼霜及其制备方法
WO2022140467A1 (en) Topical compositions and methods of treating skin diseases and conditions with such compositions
US11197831B2 (en) Compositions comprising at least one dispersed active principle and lipid microcapsules